Sub-Total: $0.00
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Complimentary
Related products
-
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more -
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more -
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Read more -
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more
